Eledon Pharmaceuticals, Inc. · NASDAQ:ELDN
The Vanguard Group's stake in Eledon Pharmaceuticals, Inc. fell below 5% (Schedule 13G/A)
Event Mar 13, 2026 · Filed Mar 26, 2026
The Vanguard Group's stake in Eledon Pharmaceuticals, Inc. fell below 5%, 0 shares, as a passive investor on Mar 13, 2026. Filed Mar 26, 2026 (Schedule 13G/A).
- Stake
- 0%
- Shares
- 0
- Intent
- Passive
- What changed
- Fell below 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| The Vanguard Group | 0% | 0 |
Source
Related
- Eledon Pharmaceuticals, Inc.
- The Vanguard Group
- Eledon Pharmaceuticals, Inc. shareholders
- Schedule 13G · The Vanguard Group · Jul 29, 2025
- Form 4 · Gros David-Alexandre C · Aug 4, 2026
- Form 4 · Perrin Steven · Aug 4, 2026
- Schedule 13G · Vanguard Capital Management LLC · Jul 31, 2026
- Schedule 13G/A · Bvf Partners L P · May 15, 2026
- Schedule 13G · BlackRock, Inc. · Apr 27, 2026